publication . Article . Review . 2018

ebb® Complete Tamponade System: effective hemostasis for postpartum hemorrhage

McQuivey,Ross W; Block,Jon E; Massaro,Robert A;
Open Access English
  • Published: 01 Mar 2018 Journal: Medical Devices : Evidence and Research (issn: 1179-1470, Copyright policy)
  • Publisher: Dove Medical Press
Ross W McQuivey,1 Jon E Block,2 Robert A Massaro3 1Clinical Innovations, Salt Lake City, UT, USA; 2Independent Clinical Consultant, San Francisco, CA, USA; 3Monmouth Medical Center, Long Branch, NJ, USA Abstract: As a leading cause of maternal death, postpartum hemorrhage (PPH) remains a worldwide obstetrical problem. However, in most cases, mortality and morbidity can be averted if efforts are immediately undertaken to achieve hemostasis. Uterine balloon tamponade has been shown to provide effective control of PPH and avoid more invasive surgical procedures and even the emergency peripartum hysterectomy. Recent clinical recommendation suggests that balloon tamp...
free text keywords: Evidence and Research [Medical Devices], postpartum hemorrhage, balloon tamponade, hemostasis, maternal bleeding, Medical technology, R855-855.5
Related Organizations
27 references, page 1 of 2

1. American College of Obstetricians, Gynecologists. ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 76, October 2006: postpartum hemorrhage. Obstet Gynecol. 2006;108(4):1039-1047.

2. Walsfih M, Neuman A, Wlody D. Maternal haemorrhage. Br J Anaesth. 2009;103(Suppl 1):i47-i56. [OpenAIRE]

3. Calvert C, Thomas SL, Ronsmans C, Wagner KS, Adler AJ, Filippi V. Identifying regional variation in the prevalence of postpartum haemorrhage: a systematic review and meta-analysis. PLoS One. 2012;7(7): e41114.

4. Bateman BT, Berman MF, Riley LE, Leffert LR. The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anesth Analg. 2010;110(5):1368-1373.

5. Berg CJ, Harper MA, Atkinson SM, et al. Preventability of pregnancyrelated deaths: results of a state-wide review. Obstet Gynecol. 2005;106(6): 1228-1234.

6. Devine PC. Obstetric hemorrhage. Semin Perinatol. 2009;33(2):76-81.

7. Doumouchtsis SK, Papageorghiou AT, Arulkumaran S. Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails. Obstet Gynecol Surv. 2007;62(8):540-547. [OpenAIRE]

8. Doumouchtsis SK, Papageorghiou AT, Vernier C, Arulkumaran S. Management of postpartum hemorrhage by uterine balloon tamponade: prospective evaluation of effectiveness. Acta Obstet Gynecol Scand. 2008;87(8):849-855. [OpenAIRE]

9. Laas E, Bui C, Popowski T, Mbaku OM, Rozenberg P. Trends in the rate of invasive procedures after the addition of the intrauterine tamponade test to a protocol for management of severe postpartum hemorrhage. Am J Obstet Gynecol. 2012;207(4):281 e281-e287.

10. Revert M, Cottenet J, Raynal P, Cibot E, Quantin C, Rozenberg P. Intrauterine balloon tamponade for management of severe postpartum haemorrhage in a perinatal network: a prospective cohort study. BJOG. 2017;124(8):1255-1262. [OpenAIRE]

11. Sobieszczyk S, Breborowicz G. Management recommendations for postpartum hemorrhage. Arch Perinat Med. 2004;10(4):1-4.

12. Dildy GA, Belfort MA, Adair CD, et al. Initial experience with a dualballoon catheter for the management of postpartum hemorrhage. Am J Obstet Gynecol. 2014;210(2):136.e1-136.e6.

13. Prevention and management of postpartum haemorrhage: green-top guideline no. 52. BJOG. 2017;124(5):e106-e149.

14. Einerson BD, Son M, Schneider P, Fields I, Miller ES. The association between intrauterine balloon tamponade duration and postpartum hemorrhage outcomes. Am J Obstet Gynecol. 2017;216(3):300.e1-300.e5.

15. Alouini S. Excessive duration of intrauterine balloon placement. Am J Obstet Gynecol. 2017;217(2):226. [OpenAIRE]

27 references, page 1 of 2
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue